Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - ACCOUNTS PAYABLE
Accounts Payable HALO - Halozyme Therapeutics, Inc.
11.8 M
LAST VALUE
176.91%
2 YEAR CAGR
23.70%
5 YEAR CAGR
14.19%
10 YEAR CAGR